FDA
-
-
-
-
-
-
-
Acura Pharmaceuticals Provides Development Update on LTX-03
-
-
-
-
-
-
-
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
-
-
-
-
-
-
-
Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03
-
-
-
-
-
-
-
Acura Pharma (ACUR) Reports Positive Results from Study AP-LTX-301
-
-
-
-
-
-
-
Acura Pharmaceuticals to Host Second Quarter 2017 Financial Results Conference Call on August 15, 2017
-
-
-
-
-
-
-
Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed® Products
-
-
-
-
-
-
322,904 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

